Updated
NeurogesX, a San Carlos drug company developing treatments for chronic pain, has filed for an initial public offering to raise $69 million.
NeurogesX has raised about $95 million from venture firms, including Alta Partners, Arch Venture Partners, Montreux Equity Partners and Walden International.
Tags: co:NeurogesX, inv:Alta-Partners, inv:ARCH-Venture-Partners, inv:Montreux-Equity-Partners, inv:Walden-International
Trackback URL
